Peloids in Skin Care and Cosmeceuticals
Key Findings
- 21 clinical/in-vitro studies reviewed on peloids for skin care — psoriasis, eczema, acne, sensitive skin, seborrheic dermatitis
- Massaciuccoli PEAT peloid matured with bromine-iodine water: clinical trials showed decreased seborrheic dermatitis index, decreased sebum, improved hydration
- Peat peloid for gynoid lipodystrophy: decreased body diameters, improved skin elasticity, reduced subcutaneous fat
- Peloid cosmeceuticals bridge therapeutic balneology and consumer skincare — natural alternative to synthetic ingredients
- Safety and regulation of peloids discussed — EU cosmetic regulation applies to cosmeceutical use
Open-access review published in the journal Cosmetics (2024), covering peloids specifically in skin care and cosmeceutical applications. Where most peloid research comes from balneology and rheumatology journals focused on clinical therapy, this review speaks to formulation, consumer products, and the regulatory concept of cosmeceuticals — making it directly relevant to the applications covered on this site.
Scope
The review synthesises 21 clinical and in vitro studies on peloids for skin care. Conditions covered include psoriasis, eczema (atopic dermatitis), acne, sensitive skin, and seborrheic dermatitis. This is the most comprehensive recent survey of peloid skin care evidence.
Key Peat-Specific Findings
Two sets of results stand out for peat specifically:
Seborrheic dermatitis and sebum: A peat peloid matured with bromine-iodine water (Massaciuccoli peat, Italy) showed in clinical trials: decreased seborrheic dermatitis index, decreased sebum secretion, and improved skin hydration. This is one of the few clinical trials using peat for a scalp/skin condition with quantified outcomes.
Body contouring: A peat peloid application protocol for gynoid lipodystrophy (cellulite) showed decreased body diameters, improved skin elasticity, and reduced subcutaneous fat over a treatment course. This is an unusual application — most peat research focuses on inflammation and skin conditions — and the mechanism likely involves the combination of heat, circulation stimulation, and osmotic effects.
The Cosmeceutical Framing
The review positions peloids as cosmeceuticals — products that sit between cosmetics and pharmaceuticals in terms of biological activity. This framing is commercially and regulatory significant in the EU: products with measurable pharmacological effects that are sold as cosmetics must comply with EU Cosmetics Regulation, and efficacy claims require substantiation. Mourelle and Gómez argue that the existing clinical literature provides that substantiation for several peloid applications.
What It Adds
This is the most recent broad peloid skin-care review in the knowledge graph. It is also one of the few reviews to discuss formulation and regulatory context alongside efficacy data, making it useful for understanding how peat evidence translates to consumer product development.